Chemoinformaics analysis of 3-HYDROXY-4-OXOPYRAN-2,6-DICARBOXYLIC ACID
| Molecular Weight | 200.102 | nRot | 2 |
| Heavy Atom Molecular Weight | 196.07 | nRig | 6 |
| Exact Molecular Weight | 199.996 | nRing | 1 |
| Solubility: LogS | -0.25 | nHRing | 1 |
| Solubility: LogP | -2.159 | No. of Aliphatic Rings | 0 |
| Acid Count | 2 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 18 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 4 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 6 |
| nHA | 5 | APOL | 19.9712 |
| nHD | 3 | BPOL | 8.35283 |
| QED | 0.399 |
| Synth | 3.578 |
| Natural Product Likeliness | 1.579 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0.52 |
| HIA | 0.942 |
| CACO-2 | -5.269 |
| MDCK | 0.000574427 |
| BBB | 0.608 |
| PPB | 0.120751 |
| VDSS | 1.026 |
| FU | 0.765411 |
| CYP1A2-inh | 0.004 |
| CYP1A2-sub | 0.072 |
| CYP2c19-inh | 0.004 |
| CYP2c19-sub | 0.132 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.05 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.141 |
| CYP3a4-inh | 0.005 |
| CYP3a4-sub | 0.022 |
| CL | 1.437 |
| T12 | 0.405 |
| hERG | 0.066 |
| Ames | 0.075 |
| ROA | 0.036 |
| SkinSen | 0.049 |
| Carcinogencity | 0.011 |
| EI | 0.021 |
| Respiratory | 0.024 |
| NR-Aromatase | 0.004 |
| Antiviral | No |
| Prediction | 0.857582 |